High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis

Published:2014-10-09 Issue:10 Volume:9 Page:e110153
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Wei,Gong Xiaoyuan,Sun Mingyuan,Zhao Xingli,Gong Benfa,Wei Hui,Mi Yingchang,Wang Jianxiang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Acute myeloid leukemia. N Engl J Med;B Löwenberg,1999

2. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood;JF Bishop,1996

3. Sequential multiagent chemo- therapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222. Blood;JO Moore,2005

4. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in post remission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study. Blood;S Miyawaki,2011

5. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood;B Löwenberg,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fusariosis in patients with hematological malignancies: Two case reports;Medical Mycology Case Reports;2023-12

2. A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics;Cancer;2023-10-28

3. Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis;European Journal of Haematology;2023-08-28

4. A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia;Molecular and Clinical Oncology;2022-10-06

5. Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry;Clinical Lymphoma Myeloma and Leukemia;2022-10